WNT Pathway clinical trials at UCLA

1 research study open to eligible people

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
Los Angeles, California and other locations

Last updated: May 8, 2026